Total Visits

Views
Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A20

Select a period of time:

Views

Views
May 20245
June 20241
July 20243
August 20242
September 20240
October 20240
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
United Kingdom1
 

Top cities views

Views
Prineville2
Chicago2
DeKalb1
Fort Worth1